ClinConnect ClinConnect Logo
Search / Trial NCT06248073

Effectiveness of Online Program and Task-related Training for Parkinson's Disease

Launched by CHANG GUNG UNIVERSITY · Feb 7, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Telerehabilitation Early Intervention Patient Reported Outcome Assessment Self Perception

ClinConnect Summary

This clinical trial is studying how effective two different types of programs are for helping people with early-stage Parkinson's disease improve their daily activities and overall quality of life. The two programs being compared are an online self-management program, where participants learn to manage their symptoms from home, and on-site task-related training, which involves hands-on exercises in a clinic. The trial will involve people aged 45 to 70 years who have mild Parkinson's disease, and participants will be divided into three groups: one group will receive no treatment, while the other two will join one of the programs for 12 sessions, each lasting one hour, twice a week.

To be eligible for this trial, participants must be willing to sign a consent form and should not have severe cognitive or emotional issues that would hinder their participation. They should also not have received physical or occupational therapy in the past year and must be able to follow instructions. Throughout the trial, participants can expect to engage in activities that help them manage their symptoms and improve their ability to perform daily tasks. Overall, this study aims to determine which program might be more beneficial for individuals with early-stage Parkinson's disease.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • 1. Willingness to sign the informed consent form.
  • 2. Age between 45 and 70 years, with mild idiopathic Parkinson's disease and Hoehn and Yahr stage 1-2.
  • 3. No cognitive impairment.
  • 4. No severe depression that could affect the motivation to participate in the study.
  • 5. No history of shoulder dislocation or fracture that could affect body proprioception.
  • 6. No diseases that could affect the ability to reach for objects, such as stroke.
  • 7. No diseases that could affect peripheral sensation, such as diabetes.
  • 8. No severe tremors; patients whose hands, when relaxed and placed on the apparatus, still exhibit significant tremor interfering with the experiment will not be included.
  • 9. Able to follow instructions and complete the assessment process.
  • 10. Have not received physical or occupational therapy in the past year.
  • Exclusion criteria:
  • 1. Other central nervous system diseases, such as stroke.
  • 2. Have major surgery on the head or upper limbs.
  • 3. Inability to perform the reaching task while sitting.

About Chang Gung University

Chang Gung University, located in Taiwan, is a leading institution dedicated to advancing medical research and education. Renowned for its commitment to innovation and excellence in healthcare, the university actively sponsors clinical trials aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a multidisciplinary approach, Chang Gung University collaborates with various healthcare professionals and researchers to explore novel therapies and interventions across a range of medical fields, ensuring that its clinical research initiatives adhere to the highest ethical and scientific standards.

Locations

Linkou, , Taiwan

Patients applied

0 patients applied

Trial Officials

Kuan-yi Li, PhD

Principal Investigator

Chang Gung University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported